Dates of data collection |
18–24 March |
25–27 March |
8–10 April |
29 April to 4 May |
Number of evaluable respondents |
59 |
55 |
61 |
63 |
For ongoing trials, the % of clinics allowing: |
|
|
|
|
Patients to attend onsite trial visits |
71% |
60% |
57% |
74.6% |
New enrolment into ongoing trials |
22% |
15% |
NA |
NA |
Onsite clinical research associate monitoring visits |
16% |
11% |
NA |
NA |
Study drug to be shipped to patients |
55% |
66% |
67% |
65.1% |
New trials |
|
|
|
|
Trial set-up activities to continue |
57% |
60% |
52% |
71.4% |
Site initiation visits |
5% |
14% |
NA |
NA |
CFTR调制器扩展开放标签研究的启动 |
91% |
78% |
NA |
NA |
The % of clinics who received guidance from: |
|
|
|
|
Hospital |
55% |
68% |
NA |
NA |
Ethics committee |
34% |
23% |
NA |
NA |
National competent authority |
20% |
32% |
NA |
NA |
Sponsor |
88% |
90% |
97% |
93.7% |